ADARx Pharmaceuticals

Ada Rx Pharmaceuticals

Biotechnology, 5871 Oberlin Dr, San Diego, California, 92121, United States, 11-50 Employees

adarx.com

  • twitter
  • LinkedIn

phone no Phone Number: 87***********

Who is ADARX PHARMACEUTICALS

ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics. ADARx has developed p...

Read More

map
  • 5871 Oberlin Dr, San Diego, California, 92121, United States Headquarters: 5871 Oberlin Dr, San Diego, California, 92121, United States
  • 2019 Date Founded: 2019
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies
  • Zhen Li CEO:   Zhen Li

industries-icon Industry: Biotechnology

SIC SIC Code: 5122

checked-icon Does something look wrong? Fix it. | View contact records from ADARX PHARMACEUTICALS

ADARx Pharmaceuticals Org Chart and Mapping

Zhen Li

Chief Executive Officer

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding ADARx Pharmaceuticals

Answer: ADARx Pharmaceuticals's headquarters are located at 5871 Oberlin Dr, San Diego, California, 92121, United States

Answer: ADARx Pharmaceuticals's phone number is 87***********

Answer: ADARx Pharmaceuticals's official website is https://adarx.com

Answer: ADARx Pharmaceuticals's revenue is $5 Million to $10 Million

Answer: ADARx Pharmaceuticals's SIC: 5122

Answer: ADARx Pharmaceuticals has 11-50 employees

Answer: ADARx Pharmaceuticals is in Biotechnology

Answer: ADARx Pharmaceuticals contact info: Phone number: 87*********** Website: https://adarx.com

Answer: ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics. ADARx has developed proprietary RNA targeting platforms and oligonucleotide delivery technologies for inhibition, degradation, and editing disease-causing mRNA. ADARx has a growing pipeline of RNA targeting therapeutics for treating diseases across a range of therapeutic areas including genetic, cardiometabolic, complement-mediated diseases and central nervous system diseases. We are well-financed by a syndicate of renowned VC firms. ADARx currently has multiple active programs in development. Our lead candidate is at the clinical stage.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access